Overview
Transaction Name:
Novartis AG / Regulus Therapeutics Inc.
Acquirer:
Novartis AG
Target:
Regulus Therapeutics Inc.
Announcement Date:
April 30, 2025
Status:
Pending
Find a Filter
Go
Show Active Filters
Collapse All
|
Expand All
Loading...
of